- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Vtesse, Inc., a Mallinckrodt Pharmaceuticals Company
Total 30 results
-
Vtesse, LLC, a Mallinckrodt Pharmaceuticals CompanyCompletedNiemann-Pick Disease, Type C1United States
-
Vtesse, LLC, a Mallinckrodt Pharmaceuticals CompanyWithdrawnNiemann-Pick Disease, Type C
-
Therakos, Inc., a Mallinckrodt CompanyTerminatedSteroid Refractory Acute Graft Versus Host DiseaseUnited States, Spain, France, Austria, Germany, Hungary, Italy, United Kingdom
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...Completed
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...CompletedJaundice | Neonatal Hyperbilirubinemia
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...CompletedHyperbilirubinemia, Neonatal
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...TerminatedHyperbilirubinemia, NeonatalUnited States, Spain, Poland, Ukraine
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...No longer availableHyperbilirubinemia | Neonatal JaundiceUnited States
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...CompletedHyperbilirubinemia, Neonatal | Jaundice, NeonatalUnited States
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...Terminated
-
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...National Children's Hospital, VietnamCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingPrimary Hyperoxaluria Type 3United States, Germany, United Kingdom, Canada, Poland
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyAvailablePrimary Hyperoxaluria Type 1 (PH1)
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, United States, Ireland, Belgium, New Zealand, Spain, Netherlands, Portugal, Canada, Australia, France, Austria, Germany, Sweden
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingSolid Tumor, Adult | Refractory TumorUnited States
-
Alexion Pharmaceuticals, Inc.Eidos Therapeutics, a BridgeBio companyActive, not recruitingSymptomatic Transthyretin Amyloid CardiomyopathyJapan
-
Northwestern UniversityGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.Completed
-
University of CincinnatiGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.CompletedKidney TransplantationUnited States
-
Boston CollegeGrand Challenges Canada; InfaCare Pharmaceuticals Corporation, a Mallinckrodt... and other collaboratorsActive, not recruitingParent-Child Relations | Parenting | Child Development | Child MalnutritionRwanda
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Genzyme, a Sanofi Company; Millennium Pharmaceuticals...CompletedMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterGenzyme, a Sanofi Company; Otsuka Pharmaceutical Development & Commercialization...CompletedAcute Myeloblastic LeukemiaUnited States, Canada
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genzyme,... and other collaboratorsCompletedAcute Lymphoblastic LeukemiaUnited States
-
Bioverativ, a Sanofi companyAssign Data Management and Biostatistics GmbH; Quest Diagnostics-Nichols Insitute and other collaboratorsCompletedEnd-stage Renal Disease (ESRD) | Cold Agglutinin Disease (CAD) | Bullous Pemphigoid (BP) | Warm Autoimmune Hemolytic Anemia (WAIHA)Austria
-
Medstar Health Research InstituteEli Lilly and Company; Novo Nordisk A/S; Bayer; Pfizer; Medstar Diabetes Institute;; American Diabetes Association and other collaboratorsCompletedCardiovascular Disease | DiabetesUnited States